Search

Renfeng Guo

from Ann Arbor, MI
Age ~55
Get Report
Also known as:
Ren-Feng Guo, Ren Feng Guo, Renfeng Guolei Sun, Feng Guo Ren, Guo Renfeng
Phone and address:
5816 Villa France Ave, Ann Arbor, MI 48103
(734) 327-6123
Related to:
Ren-Feng Guo, 55Sun Lei, 54
Connected to:
Al J Guo, 81Alan W Guo, 33Alaw Guo, 51Albert F Guo, 33Andi Guo, 36Anna Guo, 30Baogang Guo, 64Binmiao Guo, 53Bolei Guo, 45Chunhua Guo, 63

Renfeng Guo Phones & Addresses

  • 5816 Villa France Ave, Ann Arbor, MI 48103 (734) 327-6123
  • 5816 Villa France Ave APT 172, Ann Arbor, MI 48103 (734) 327-6123
  • 821 Gallery Ln, Ann Arbor, MI 48103 (734) 255-0321

Work

Company: Inflarx Jan 2008 Position: Chief strategy officer and co-founder

Education

Degree: Doctor of Medicine, Doctorates School / High School: Norman Bethune University of Medical Sciences

Skills

Immunology • Infectious Diseases • Pharmaceutical Industry • Drug Development • Cancer Research • Medicine • Inflammation • Molecular Biology • Lifesciences • Biochemistry • Cell Biology • Drug Discovery • Cell Culture • Biotechnology • Protein Chemistry

Industries

Biotechnology

Resumes

Resumes

Renfeng Guo Photo 1

Chief Strategy Officer And Co-Founder

View page
Location:
Ann Arbor, MI
Industry:
Biotechnology
Work:
Inflarx
Chief Strategy Officer and Co-Founder
University of Michigan Medical School
Adjunct Associate Professor
Education:
Norman Bethune University of Medical Sciences
Doctor of Medicine, Doctorates Beijing Institute of Radiation Medicine
Master of Science, Masters, Immunology University of Michigan Medical School
Skills:
Immunology
Infectious Diseases
Pharmaceutical Industry
Drug Development
Cancer Research
Medicine
Inflammation
Molecular Biology
Lifesciences
Biochemistry
Cell Biology
Drug Discovery
Cell Culture
Biotechnology
Protein Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Renfeng Guo
Principal
Inflarx Inc
Whol Drugs/Sundries
5816 Villa France Ave, Ann Arbor, MI 48103

Publications

Us Patents

Compositions And Methods For The Diagnosis And Treatment Of Sepsis

View page
US Patent:
20040166541, Aug 26, 2004
Filed:
Nov 5, 2003
Appl. No.:
10/701871
Inventors:
Renfeng Guo - Ann Arbor MI, US
Niels Riedemann - Hannover, DE
Peter Ward - Ann Arbor MI, US
Markus Huber-Lang - Blaustein-Arnegg, DE
J. Sarma - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
G01N033/567
US Classification:
435/007210
Abstract:
The present invention relates to methods and compositions for the diagnosis and treatment of sepsis. The present invention also provides methods of providing a prognosis to a patient with sepsis. In particular, the present invention relates to compositions and methods for the detection of C5aR expression and the correlation of C5aR expression level with prognosis in sepsis.

Anti-C5A Binding Moieties With High Blocking Activity

View page
US Patent:
20120231008, Sep 13, 2012
Filed:
Nov 26, 2010
Appl. No.:
13/512334
Inventors:
Renfeng Guo - Ann Arbor MI, US
Niels Christoph Reidemann - Jena, DE
Yan Li - Beijing, CN
Beifen Shen - Beijing, CN
International Classification:
A61K 39/395
C07H 21/04
A61K 31/7088
C07K 16/00
US Classification:
4241391, 5303879, 536 231, 5303873, 5303871, 514 44 R, 4241301
Abstract:
The present invention relates to binding moieties that specifically bind to a conformational epitope of C5a, in particular human C5a. Preferred binding moieties are anti-C5a antibodies that bind to this conformational epitope. The binding moieties described herein are useful as active agents in pharmaceutical compositions for the treatment and prevention of various acute and chronic diseases, in particular acute inflammatory diseases, such as the systemic inflammatory response syndrome (SIRS), and different degrees of sepsis including sepsis, severe sepsis, and septic shock.

Fused Piperidinyl Bicyclic And Related Compounds As Modulators Of C5A Receptor

View page
US Patent:
20210403433, Dec 30, 2021
Filed:
Sep 9, 2021
Appl. No.:
17/470980
Inventors:
- Jena, DE
RENFENG GUO - ANN ARBOR MI, US
NIELS CHRISTOPH RIEDEMANN - JENA, DE
Assignee:
InflaRx GmbH - Jena
International Classification:
C07D 215/54
C07D 405/12
Abstract:
The present invention relates to fused piperidinyl bicyclic, meta-substituted piperidinyl and their related compounds that modulate activities of mammalian C5a receptor by directly binding to the C5a receptor. The invention also relates to pharmaceutical compositions containing such compounds and their use in the treatment of a disease or a disorder involving pathogenic activation of C5a receptors.

Fused Piperidinyl Bicyclic And Related Compounds As Modulators Of C5A Receptor

View page
US Patent:
20200290969, Sep 17, 2020
Filed:
Feb 7, 2020
Appl. No.:
16/784951
Inventors:
- Jena, DE
RENFENG GUO - ANN ARBOR MI, US
NIELS CHRISTOPH RIEDEMANN - JENA, DE
Assignee:
InflaRx GmbH - Jena
International Classification:
C07D 215/54
C07D 405/12
Abstract:
The present invention relates to fused piperidinyl bicyclic, meta-substituted piperidinyl and their related compounds that modulate activities of mammalian C5a receptor by directly binding to the C5a receptor. The invention also relates to pharmaceutical compositions containing such compounds and their use in the treatment of a disease or a disorder involving pathogenic activation of C5a receptors.
Control profile
Renfeng Guo from Ann Arbor, MI, age ~55 Get Report